Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy - RELEASE
Study identifier:D5890L00012
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
No
Study drug
Budesonide/formoterol
Sex
All
Actual Enrollment
550
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Sept 2005
Primary Completion Date: -
Study Completion Date: 01 Dec 2006
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Iain Small
General Practitioner
